Fasting reduces the incidence of vincristine‐associated adverse events in dogs

Fasting has been shown to decrease chemotherapy‐associated adverse events (AEs), in part through insulin‐like growth factor (IGF‐1) reduction, and may induce a protective effect on normal cells during chemotherapy treatment in mice and people. The purpose of this study was to evaluate the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales: Duckett, Margaret E., Curran, Kaitlin M., Leeper, Haley J., Ruby, Carl E., Bracha, Shay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891372/
https://www.ncbi.nlm.nih.gov/pubmed/33448618
http://dx.doi.org/10.1111/vco.12638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891372/
https://www.ncbi.nlm.nih.gov/pubmed/33448618
http://dx.doi.org/10.1111/vco.12638

Ejemplares similares